AXT Q3 2025 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $28.0 million, a significant increase from $18.0 million in Q2 2025 and $23.6 million in Q3 2024.

Product Breakdown:

Indium Phosphide: $13.1 million

Gallium Arsenide: $7.5 million

Germanium Substrates: $640,000

Raw Material Joint Ventures: $6.7 million

Gross Margin: Non-GAAP gross margin improved to 22.4%, up from 8.2% in Q2 2025 and 24.3% in Q3 2024. GAAP gross margin was 22.3%.

Operating Expenses: Non-GAAP operating expenses decreased to $6.7 million from $7.6 million in Q2 2025.

Net Loss: Non-GAAP net loss of $1.2 million ($0.03 per share) compared to a loss of $6.4 million ($0.15 per share) in Q2 2025. GAAP net loss was $1.9 million ($0.04 per share).

Cash Position: Cash and equivalents decreased by $3.9 million to $31.2 million, with accounts receivable increasing by $11 million.

2Strategic Updates and Business Highlights

Indium Phosphide Demand: Strong demand from data center applications, with a backlog of over $49 million, the highest in company history.

Export Permits: Successful acquisition of export permits for significant orders, although processing times have increased to approximately 60 business days.

Customer Engagement: Increased engagement with new Tier 1 customers, including optical transceiver module makers.

Manufacturing Capacity: AXT has ample capacity to meet increased demand and can quickly scale output if needed.

3Forward Guidance and Outlook

Q4 Revenue Guidance: Expected revenue in the range of $27 million to $30 million, contingent on the timing and success of obtaining export permits.

Profitability Outlook: Non-GAAP net loss projected to be between $0.01 and $0.03 per share, with GAAP net loss expected between $0.03 and $0.05 per share.

Operational Focus: Continued emphasis on improving gross margins, operational efficiency, and inventory reduction.

4Bad News, Challenges, or Points of Concern

Geopolitical Risks: The timing and success of obtaining export permits remain a significant gating factor for growth.

Operating Expenses: Expected increase in Q4 operating expenses to approximately $9 million due to end-of-year adjustments.

Market Dynamics: The germanium substrate market is experiencing poor gross margin potential, and sales are not expected to grow in Q4.

5Notable Q&A Insights

Customer Behavior: Customers are placing longer-term orders to mitigate risks associated with the permit process, indicating a shift from just-in-time ordering.

Backlog Dynamics: The current backlog includes both customers with existing permits and those still in the permit phase, reflecting confidence in future permit approvals.

Capacity Expansion: AXT could potentially double its indium phosphide capacity within nine months with an estimated investment of $10 million to $15 million.

Market Demand: There is a strong belief in sustained demand driven by AI and data center expansion, with indications of a multi-year growth cycle rather than a one-time spike. This summary encapsulates the key financial metrics, strategic initiatives, forward guidance, and notable insights from the Q&A, providing a balanced view of AXT's performance and outlook.